Drug Discovery Services Market

Drug Discovery Services Market Analysis by Process (Target Selection, Target Validation, Hit-To-Lead Identification), by Type (Medicinal Chemistry, Biology Services, Pharmacokinetics), by Drug Type (Small Molecules and Biologics) by Therapeutic Area, by Region - Global Market Insights 2022-2032

Analysis of Drug Discovery Services market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Request FREE Sample

Table of Content

1. Global Economic Outlook

2. Global Drug Discovery Services Market - Executive Summary

3. Global Drug Discovery Services Market Overview

    3.1. Introduction

        3.1.1. Global Drug Discovery Services Market Taxonomy

        3.1.2. Global Drug Discovery Services Market Definition

    3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2015-2032

        3.2.1. Global Drug Discovery Services Market Y-o-Y Growth

    3.3. Global Drug Discovery Services Market Dynamics

    3.4. Supply Chain

    3.5. Cost Structure

    3.6. PESTL Analysis 

    3.7. Product Life Cycle Analysis

    3.8. Drug Discovery & Development Process

    3.9. Roadmap to Optimize Regulatory and Commercial Success

    3.10. Evolution of R&D Drug Discovery Outsourcing

    3.11. Service Provider List

    3.12. Key Participants Market Presence (Intensity Map) By Region

4. Global Drug Discovery Services Market Analysis and Forecast 2015-2032 

    4.1. Global Drug Discovery Services Market Size and Forecast by Process, 2015-2032

        4.1.1. Target Selection Market Size and Forecast, 2015-2032

            4.1.1.1. Revenue (US$ Mn) Comparison, By Region

            4.1.1.2. Market Share Comparison, By Region

            4.1.1.3. Y-o-Y growth Comparison, By Region

        4.1.2. Target Validation Market Size and Forecast, 2015-2032

            4.1.2.1. Revenue (US$ Mn) Comparison, By Region

            4.1.2.2. Market Share Comparison, By Region

            4.1.2.3. Y-o-Y growth Comparison, By Region

        4.1.3. Hit-To-Lead Identification Market Size and Forecast, 2015-2032

            4.1.3.1. Revenue (US$ Mn) Comparison, By Region

            4.1.3.2. Market Share Comparison, By Region

            4.1.3.3. Y-o-Y growth Comparison, By Region

        4.1.4. Lead Optimization Market Size and Forecast, 2015-2032

            4.1.4.1. Revenue (US$ Mn) Comparison, By Region

            4.1.4.2. Market Share Comparison, By Region

            4.1.4.3. Y-o-Y growth Comparison, By Region

        4.1.5. Candidate Validation Market Size and Forecast, 2015-2032

            4.1.5.1. Revenue (US$ Mn) Comparison, By Region

            4.1.5.2. Market Share Comparison, By Region

            4.1.5.3. Y-o-Y growth Comparison, By Region

    4.2. Global Drug Discovery Services Market Size and Forecast By Type, 2015-2032

        4.2.1. Medicinal Chemistry Market Size and Forecast, 2015-2032

            4.2.1.1. Revenue (US$ Mn) Comparison, By Region

            4.2.1.2. Market Share Comparison, By Region

            4.2.1.3. Y-o-Y growth Comparison, By Region

        4.2.2. Biology Services Market Size and Forecast, 2015-2032

            4.2.2.1. Revenue (US$ Mn) Comparison, By Region

            4.2.2.2. Market Share Comparison, By Region

            4.2.2.3. Y-o-Y growth Comparison, By Region

        4.2.3. Drug Metabolism and Pharmacokinetics Market Size and Forecast, 2015-2032

            4.2.3.1. Revenue (US$ Mn) Comparison, By Region

            4.2.3.2. Market Share Comparison, By Region

            4.2.3.3. Y-o-Y growth Comparison, By Region

    4.3. Global Drug Discovery Services Market Size and Forecast By Drug Type, 2015-2032

        4.3.1. Small Molecules Market Size and Forecast, 2015-2032

            4.3.1.1. Revenue (US$ Mn) Comparison, By Region

            4.3.1.2. Market Share Comparison, By Region

            4.3.1.3. Y-o-Y growth Comparison, By Region

        4.3.2. Biologics Market Size and Forecast, 2015-2032

            4.3.2.1. Revenue (US$ Mn) Comparison, By Region

            4.3.2.2. Market Share Comparison, By Region

            4.3.2.3. Y-o-Y growth Comparison, By Region

    4.4. Global Drug Discovery Services Market Size and Forecast By Therapeutic Area, 2015-2032

        4.4.1. Oncology Market Size and Forecast, 2015-2032

            4.4.1.1. Revenue (US$ Mn) Comparison, By Region

            4.4.1.2. Market Share Comparison, By Region

            4.4.1.3. Y-o-Y growth Comparison, By Region

        4.4.2. Neurology Market Size and Forecast, 2015-2032

            4.4.2.1. Revenue (US$ Mn) Comparison, By Region

            4.4.2.2. Market Share Comparison, By Region

            4.4.2.3. Y-o-Y growth Comparison, By Region

        4.4.3. Respiratory Diseases Market Size and Forecast, 2015-2032

            4.4.3.1. Revenue (US$ Mn) Comparison, By Region

            4.4.3.2. Market Share Comparison, By Region

            4.4.3.3. Y-o-Y growth Comparison, By Region

        4.4.4. Respiratory Diseases Market Size and Forecast, 2015-2032

            4.4.4.1. Revenue (US$ Mn) Comparison, By Region

            4.4.4.2. Market Share Comparison, By Region

            4.4.4.3. Y-o-Y growth Comparison, By Region

        4.4.5. Diabetes Market Size and Forecast, 2015-2032

            4.4.5.1. Revenue (US$ Mn) Comparison, By Region

            4.4.5.2. Market Share Comparison, By Region

            4.4.5.3. Y-o-Y growth Comparison, By Region

        4.4.6. Other Therapeutic Areas Market Size and Forecast, 2015-2032

            4.4.6.1. Revenue (US$ Mn) Comparison, By Region

            4.4.6.2. Market Share Comparison, By Region

            4.4.6.3. Y-o-Y growth Comparison, By Region

5. North America Drug Discovery Services Market Size and Forecast, 2015-2032

    5.1. North America Outlook 

    5.2. North America Parent Market Outlook 

    5.3. North America Target Market Outlook 

    5.4. Revenue (US$ Mn) Comparison, By Country 

        5.4.1. US Market Size and Forecast (US$ Mn), 2015-2032

        5.4.2. Canada Market Size and Forecast (US$ Mn), 2015-2032

    5.5. Revenue (US$ Mn) Comparison, By Process  

    5.6. Revenue (US$ Mn) Comparison, By Type 

    5.7. Revenue (US$ Mn) Comparison, By Drug Type 

    5.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

6. Latin America Drug Discovery Services Market Size and Forecast, 2015-2032

    6.1. Latin America Outlook 

    6.2. Latin America Parent Market Outlook 

    6.3. Latin America Target Market Outlook 

    6.4. Revenue (US$ Mn) Comparison, By Country 

        6.4.1. Brazil Market Size and Forecast (US$ Mn), 2015-2032

        6.4.2. Mexico Market Size and Forecast (US$ Mn), 2015-2032

        6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2015-2032

    6.5. Revenue (US$ Mn) Comparison, By Process  

    6.6. Revenue (US$ Mn) Comparison, By Type 

    6.7. Revenue (US$ Mn) Comparison, By Drug Type 

    6.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

7. Europe Drug Discovery Services Market Size and Forecast, 2015-2032

    7.1. Europe Outlook 

    7.2. Europe Parent Market Outlook 

    7.3. Europe Target Market Outlook 

    7.4. Revenue (US$ Mn) Comparison, By Country 

        7.4.1. Germany Market Size and Forecast (US$ Mn), 2015-2032

        7.4.2. UK Market Size and Forecast (US$ Mn), 2015-2032

        7.4.3. France Market Size and Forecast (US$ Mn), 2015-2032

        7.4.4. Spain Market Size and Forecast (US$ Mn), 2015-2032

        7.4.5. Italy Market Size and Forecast (US$ Mn), 2015-2032

        7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2015-2032

    7.5. Revenue (US$ Mn) Comparison, By Process  

    7.6. Revenue (US$ Mn) Comparison, By Type 

    7.7. Revenue (US$ Mn) Comparison, By Drug Type 

    7.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

8. Japan Drug Discovery Services Market Size and Forecast, 2015-2032

    8.1. Japan Outlook 

    8.2. Japan Parent Market Outlook 

    8.3. Japan Target Market Outlook 

    8.4. Revenue (US$ Mn) Comparison, By Country 

        8.4.1. Japan Market Size and Forecast (US$ Mn), 2015-2032

    8.5. Revenue (US$ Mn) Comparison, By Process  

    8.6. Revenue (US$ Mn) Comparison, By Type 

    8.7. Revenue (US$ Mn) Comparison, By Drug Type 

    8.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

9. APEJ Drug Discovery Services Market Size and Forecast, 2015-2032

    9.1. APEJ Outlook 

    9.2. APEJ Parent Market Outlook 

    9.3. APEJ Target Market Outlook 

    9.4. Revenue (US$ Mn) Comparison, By Country 

        9.4.1. China Market Size and Forecast (US$ Mn), 2015-2032

        9.4.2. India Market Size and Forecast (US$ Mn), 2015-2032

        9.4.3. Thailand Market Size and Forecast (US$ Mn), 2015-2032

        9.4.4. Singapore Market Size and Forecast (US$ Mn), 2015-2032

        9.4.5. Australia Market Size and Forecast (US$ Mn), 2015-2032

        9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2015-2032

    9.5. Revenue (US$ Mn) Comparison, By Process  

    9.6. Revenue (US$ Mn) Comparison, By Type 

    9.7. Revenue (US$ Mn) Comparison, By Drug Type 

    9.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

10. MEA Drug Discovery Services Market Size and Forecast, 2015-2032

    10.1. MEA Outlook 

    10.2. MEA Parent Market Outlook 

    10.3. MEA Target Market Outlook 

    10.4. Revenue (US$ Mn) Comparison, By Country 

        10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2015-2032

        10.4.2. South Africa Market Size and Forecast (US$ Mn), 2015-2032

        10.4.3. Israel Market Size and Forecast (US$ Mn), 2015-2032

        10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2015-2032

    10.5. Revenue (US$ Mn) Comparison, By Process  

    10.6. Revenue (US$ Mn) Comparison, By Type 

    10.7. Revenue (US$ Mn) Comparison, By Drug Type 

    10.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 

11. Global Drug Discovery Services Market Company Share, Competition Landscape and Company Profiles

    11.1. Company Share Analysis

    11.2. Competition Landscape

    11.3. Company Profiles

        11.3.1. Thermo Fisher Scientific, Inc.

        11.3.2. GE Healthcare

        11.3.3. Charles River Laboratories International

        11.3.4. Agilent Technologies, Inc.

        11.3.5. Eli Lilly and Company

        11.3.6. Lonza Group Ltd

        11.3.7. WuXi AppTec Co. Ltd.

        11.3.8. Evotec AG

        11.3.9. Pharmaceutical Product Development LLC

        11.3.10. Merck Millipore 

        11.3.11. Albany Molecular Research, Inc.

        11.3.12. Covance Inc.

        11.3.13. Genscript Biotech Corporation

        11.3.14. Aurigene Discovery Technologies Limited

        11.3.15. Syngene International Limited

        11.3.16. Promega Corporation

        11.3.17. SRI International, Inc.

        11.3.18. Chembridge Corporation

        11.3.19. GVK Biosciences Private Limited

        11.3.20. Domainex Ltd.

        11.3.21. Selcia Limited

        11.3.22. Viva Biotech Ltd.

        11.3.23. Jubilant Biosys Limited

        11.3.24. Ubiquigent Limited

        11.3.25. ReproCELL, Inc.

        11.3.26. DiscoverX Corporation

        11.3.27. Creative Bioarray

    11.4. Key Takeaways

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

TABLE 1 Global Drug Discovery Services Market Value (US$ Mn), 2015-2021

TABLE 2 Global Drug Discovery Services Market Value (US$ Mn), 2022-2032

TABLE 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2022-2032

TABLE 4 Global Target Selection Segment Value (US$ Mn), By Region 2015-2021

TABLE 5 Global Target Selection Segment Value (US$ Mn), By Region 2022-2032

TABLE 6 Global Target Selection Segment Market Share, By Region 2015-2021

TABLE 7 Global Target Selection Segment Market Share, By Region 2022-2032

TABLE 8 Global Target Selection Segment Y-o-Y, By Region 2022-2032

TABLE 9 Global Target Validation Segment Value (US$ Mn), By Region 2015-2021

TABLE 10 Global Target Validation Segment Value (US$ Mn), By Region 2022-2032

TABLE 11 Global Target Validation Segment Market Share, By Region 2015-2021

TABLE 12 Global Target Validation Segment Market Share, By Region 2022-2032

TABLE 13 Global Target Validation Segment Y-o-Y, By Region 2022-2032

TABLE 14 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2015-2021

TABLE 15 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2022-2032

TABLE 16 Global Hit-To-Lead Identification Segment Market Share, By Region 2015-2021

TABLE 17 Global Hit-To-Lead Identification Segment Market Share, By Region 2022-2032

TABLE 18 Global Hit-To-Lead Identification Segment Y-o-Y, By Region 2022-2032

TABLE 19 Global Lead Optimization Segment Value (US$ Mn), By Region 2015-2021

TABLE 20 Global Lead Optimization Segment Value (US$ Mn), By Region 2022-2032

TABLE 21 Global Lead Optimization Segment Market Share, By Region 2015-2021

TABLE 22 Global Lead Optimization Segment Market Share, By Region 2022-2032

TABLE 23 Global Lead Optimization Segment Y-o-Y, By Region 2022-2032

TABLE 24 Global Candidate Validation Segment Value (US$ Mn), By Region 2015-2021

TABLE 25 Global Candidate Validation Segment Value (US$ Mn), By Region 2022-2032

TABLE 26 Global Candidate Validation Segment Market Share, By Region 2015-2021

TABLE 27 Global Candidate Validation Segment Market Share, By Region 2022-2032

TABLE 28 Global Candidate Validation Segment Y-o-Y, By Region 2022-2032

TABLE 29 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2015-2021

TABLE 30 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2022-2032

TABLE 31 Global Medicinal Chemistry Segment Market Share, By Region 2015-2021

TABLE 32 Global Medicinal Chemistry Segment Market Share, By Region 2022-2032

TABLE 33 Global Medicinal Chemistry Segment Y-o-Y, By Region 2022-2032

TABLE 34 Global Biology Services Segment Value (US$ Mn), By Region 2015-2021

TABLE 35 Global Biology Services Segment Value (US$ Mn), By Region 2022-2032

TABLE 36 Global Biology Services Segment Market Share, By Region 2015-2021

TABLE 37 Global Biology Services Segment Market Share, By Region 2022-2032

TABLE 38 Global Biology Services Segment Y-o-Y, By Region 2022-2032

TABLE 39 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2015-2021

TABLE 40 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2022-2032

TABLE 41 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2015-2021

TABLE 42 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2022-2032

TABLE 43 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y, By Region 2022-2032

TABLE 44 Global Small Molecules Segment Value (US$ Mn), By Region 2015-2021

TABLE 45 Global Small Molecules Segment Value (US$ Mn), By Region 2022-2032

TABLE 46 Global Small Molecules Segment Market Share, By Region 2015-2021

TABLE 47 Global Small Molecules Segment Market Share, By Region 2022-2032

TABLE 48 Global Small Molecules Segment Y-o-Y, By Region 2022-2032

TABLE 49 Global Biologics Segment Value (US$ Mn), By Region 2015-2021

TABLE 50 Global Biologics Segment Value (US$ Mn), By Region 2022-2032

TABLE 51 Global Biologics Segment Market Share, By Region 2015-2021

TABLE 52 Global Biologics Segment Market Share, By Region 2022-2032

TABLE 53 Global Biologics Segment Y-o-Y, By Region 2022-2032

TABLE 54 Global Oncology Segment Value (US$ Mn), By Region 2015-2021

TABLE 55 Global Oncology Segment Value (US$ Mn), By Region 2022-2032

TABLE 56 Global Oncology Segment Market Share, By Region 2015-2021

TABLE 57 Global Oncology Segment Market Share, By Region 2022-2032

TABLE 58 Global Oncology Segment Y-o-Y, By Region 2022-2032

TABLE 59 Global Neurology Segment Value (US$ Mn), By Region 2015-2021

TABLE 60 Global Neurology Segment Value (US$ Mn), By Region 2022-2032

TABLE 61 Global Neurology Segment Market Share, By Region 2015-2021

TABLE 62 Global Neurology Segment Market Share, By Region 2022-2032

TABLE 63 Global Neurology Segment Y-o-Y, By Region 2022-2032

TABLE 64 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2015-2021

TABLE 65 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2022-2032

TABLE 66 Global Cardiovascular Diseases Segment Market Share, By Region 2015-2021

TABLE 67 Global Cardiovascular Diseases Segment Market Share, By Region 2022-2032

TABLE 68 Global Cardiovascular Diseases Segment Y-o-Y, By Region 2022-2032

TABLE 69 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2015-2021

TABLE 70 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2022-2032

TABLE 71 Global Respiratory Diseases Segment Market Share, By Region 2015-2021

TABLE 72 Global Respiratory Diseases Segment Market Share, By Region 2022-2032

TABLE 73 Global Respiratory Diseases Segment Y-o-Y, By Region 2022-2032

TABLE 74 Global Diabetes Segment Value (US$ Mn), By Region 2015-2021

TABLE 75 Global Diabetes Segment Value (US$ Mn), By Region 2022-2032

TABLE 76 Global Diabetes Segment Market Share, By Region 2015-2021

TABLE 77 Global Diabetes Segment Market Share, By Region 2022-2032

TABLE 78 Global Diabetes Segment Y-o-Y, By Region 2022-2032

TABLE 79 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2015-2021

TABLE 80 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2022-2032

TABLE 81 Global Other Therapeutic Areas Segment Market Share, By Region 2015-2021

TABLE 82 Global Other Therapeutic Areas Segment Market Share, By Region 2022-2032

TABLE 83 Global Other Therapeutic Areas Segment Y-o-Y, By Region 2022-2032

TABLE 84 North America Current Expenditure on Health, (% of GDP), by Country, 2022-2032

TABLE 85 North America Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032

TABLE 86 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032

TABLE 87 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032

TABLE 88 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032

TABLE 89 North America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

TABLE 90 North America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

TABLE 91 North America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

TABLE 92 North America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

TABLE 93 North America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

TABLE 94 North America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

TABLE 95 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

TABLE 96 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

TABLE 97 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

TABLE 98 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

TABLE 99 Latin America Current Expenditure on Health, (% of GDP), by Country, 2022-2032

TABLE 100 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032

TABLE 101 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032

TABLE 102 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032

TABLE 103 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032

TABLE 104 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

TABLE 105 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

TABLE 106 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

TABLE 107 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

TABLE 108 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

TABLE 109 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

TABLE 110 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

TABLE 111 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

TABLE 112 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

TABLE 113 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

TABLE 114 Europe Current Expenditure on Health, (% of GDP), by Country, 2022-2032

TABLE 115 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032

TABLE 116 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032

TABLE 117 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032

TABLE 118 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032

TABLE 119 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

TABLE 120 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

TABLE 121 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

TABLE 122 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

TABLE 123 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

TABLE 124 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

TABLE 125 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

TABLE 126 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

TABLE 127 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

TABLE 128 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

TABLE 129 Japan Current Expenditure on Health, (% of GDP), by Country, 2022-2032

TABLE 130 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032

TABLE 131 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032

TABLE 132 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032

TABLE 133 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032

TABLE 134 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

TABLE 135 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

TABLE 136 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

TABLE 137 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

TABLE 138 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

TABLE 139 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

TABLE 140 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

TABLE 141 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

TABLE 142 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

TABLE 143 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

TABLE 144 APEJ Current Expenditure on Health, (% of GDP), by Country, 2022-2032

TABLE 145 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032

TABLE 146 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032

TABLE 147 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032

TABLE 148 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032

TABLE 149 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

TABLE 150 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

TABLE 151 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

TABLE 152 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

TABLE 153 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

TABLE 154 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

TABLE 155 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

TABLE 156 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

TABLE 157 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

TABLE 158 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

TABLE 159 MEA Current Expenditure on Health, (% of GDP), by Country, 2022-2032

TABLE 160 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032

TABLE 161 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032

TABLE 162 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032

TABLE 163 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032

TABLE 164 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

TABLE 165 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

TABLE 166 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

TABLE 167 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

TABLE 168 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

TABLE 169 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

TABLE 170 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

TABLE 171 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

TABLE 172 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

TABLE 173 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

FIG. 1 Global Drug Discovery Services Market Value (US$ Mn), 2015-2021

FIG. 2 Global Drug Discovery Services Market Value (US$ Mn) Forecast, 2022-2032

FIG. 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2022-2032

FIG. 4 Global Target Selection Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 5 Global Target Selection Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 6 Global Target Selection Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 7 Global Target Validation Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 8 Global Target Validation Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 9 Global Target Validation Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 10 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 11 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 12 Global Hit-To-Lead Identification Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 13 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 14 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 15 Global Lead Optimization Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 16 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 17 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 18 Global Candidate Validation Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 19 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 20 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 21 Global Medicinal Chemistry Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 22 Global Biology Services Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 23 Global Biology Services Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 24 Global Biology Services Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 25 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 26 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 27 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 28 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 29 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 30 Global Small Molecules Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 31 Global Biologics Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 32 Global Biologics Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 33 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 34 Global Oncology Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 35 Global Oncology Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 36 Global Oncology Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 37 Global Neurology Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 38 Global Neurology Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 39 Global Neurology Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 40 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 41 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 42 Global Cardiovascular Diseases Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 43 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 44 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 45 Global Respiratory Diseases Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 46 Global Diabetes Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 47 Global Diabetes Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 48 Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 49 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2015-2021

FIG. 50 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2022-2032

FIG. 51 Global Other Therapeutic Areas Segment Y-o-Y Growth Rate, By Region, 2022-2032

FIG. 52 North America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

FIG. 53 North America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

FIG. 54 North America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

FIG. 55 North America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

FIG. 56 North America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

FIG. 57 North America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

FIG. 58 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

FIG. 59 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

FIG. 60 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

FIG. 61 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

FIG. 62 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

FIG. 63 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

FIG. 64 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

FIG. 65 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

FIG. 66 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

FIG. 67 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

FIG. 68 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

FIG. 69 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

FIG. 70 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

FIG. 71 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

FIG. 72 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

FIG. 73 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

FIG. 74 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

FIG. 75 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

FIG. 76 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

FIG. 77 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

FIG. 78 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

FIG. 79 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

FIG. 80 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

FIG. 81 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

FIG. 82 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

FIG. 83 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

FIG. 84 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

FIG. 85 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

FIG. 86 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

FIG. 87 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

FIG. 88 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

FIG. 89 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

FIG. 90 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

FIG. 91 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

FIG. 92 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

FIG. 93 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

FIG. 94 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

FIG. 95 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

FIG. 96 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

FIG. 97 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

FIG. 98 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

FIG. 99 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

FIG. 100 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

FIG. 101 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

FIG. 102 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021

FIG. 103 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032

FIG. 104 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021

FIG. 105 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032

FIG. 106 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021

FIG. 107 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032

FIG. 108 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021

FIG. 109 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032

FIG. 110 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021

FIG. 111 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Drug Discovery Services Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services